ReviewiGIE : innovation, investigation and insights2026
Pharyngeal endoscopic submucosal dissection: detection, technique, and considerations for Western adoption.
Review in iGIE : innovation, investigation and insights, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Pharyngeal squamous cell carcinoma (SCC) is increasingly detected at earlier stages in Japan, largely due to routine image-enhanced endoscopy and systematic pharyngeal examination. Endoscopic submucosal dissection (ESD) is now a preferred minimally invasive treatment option for superficial SCC, with excellent outcomes. Despite this, the technique remains underutilized in the West, even though the incidence of pharyngeal cancer continues to rise. Methods: This review brings together current evidence on pharyngeal ESD, indications, technique, outcomes, and adverse events. Results: Across contemporary series, en bloc and R0 resection rates are consistently high, with serious adverse events occurring infrequently. Nonetheless, pharyngeal ESD involves unique challenges stemming from complex anatomy, specialized anesthesia, and specific exposure techniques. Conclusions: We highlight practical barriers limiting adoption in the West, particularly limited knowledge in optical diagnosis, and propose targeted education to close the knowledge gap. As demand increases for minimally invasive, organ-preserving treatments, pharyngeal ESD is poised to have an important role for the treatment of early pharyngeal SCC in Western practice.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.